New imaging method aims to sharpen brain tumor diagnosis
NCT ID NCT07211360
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will test whether combining PET scans with amino acid tracers and MRI can more accurately diagnose brain tumors and tell if they are growing or just reacting to treatment. Researchers will follow 270 adults with primary or secondary brain tumors, comparing the new imaging method to standard care. The goal is to improve diagnostic accuracy without adding extra procedures beyond routine practice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could improve how doctors tell whether a brain tumor is growing or just reacting to treatment, leading to more accurate diagnoses.
- What could go wrong
- This is an observational study, not a treatment trial. It only tests imaging accuracy, so it won't directly improve outcomes. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY AND SECONDARY BRAIN TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.